Editor-in-chief
Maria Stella Graziani

Deputy Director
Martina Zaninotto

Associate Editors
Ferruccio Ceriotti
Davide Giavarina
Bruna Lo Sasso
Giampaolo Merlini
Martina Montagnana
Andrea Mosca
Paola Pezzati
Rossella Tomaiuolo
Matteo Vidali

International Advisory Board Khosrow Adeli Canada
Sergio Bernardini Italy
Marcello Ciaccio Italy
Eleftherios Diamandis Canada
Philippe Gillery France
Kjell Grankvist Sweden
Hans Jacobs The Netherlands
Eric Kilpatrick UK
Magdalena Krintus Poland
Giuseppe Lippi Italy
☩Howard Morris Australia
Mario Plebani Italy
Sverre Sandberg Norway
Ana-Maria Simundic Croatia
☩Jill Tate Australia
Tommaso Trenti Italy
Cas Weykamp The Netherlands
Maria Willrich USA
Paul Yip Canada


Publisher
Biomedia srl
Via L. Temolo 4, 20126 Milano

Responsible Editor
Giuseppe Agosta

Editorial Secretary
Arianna Lucini Paioni
Biomedia srl
Via L. Temolo 4, 20126 Milano
Tel. 0245498282
email: biochimica.clinica@sibioc.it



Area soci
Non possiedi o non ricordi la password!
Clicca qui

BC: Articoli scritti da C. Bauleo

Valore predittivo della determinazione di neutrofili e granulociti immaturi nel sangue periferico per il rischio di mortalità in soggetti con patologie cardiopolmonari
Predictive value of the neutrophil and immature granulocyte blood counts for the mortality risk in subjects with cardiopulmonary disease
A. Papa  |  C. Bauleo  |  M. Fornaro  |  F. Cocci  | 
<p>&nbsp;An increase in the peripheral blood of immature granulocytes (IG) provides&nbsp;information on enhanced bone marrow activity and has been shown to be useful as predictor of infection and sepsis&nbsp;both in adults and pediatric subjects. The association between an elevated neutrophil count (NEU) and risk for cardiac&nbsp;and overall mortality has yet been proven, but in hospitalized adult patients the contribution of IG to prediction of&nbsp;death remains to be clarified. The aim of this study was to retrospectively evaluate the admission complete blood&nbsp;count and white blood cell differential generated with a Cell-Dyn Sapphire analyzer (Abbott Diagnostics) from 139&nbsp;patients affected by cardiac and/or pulmonary disease. Patients were divided into 3 groups: group A (controls)&nbsp;consisted of 40 patients with NEU and IG within reference limits; group B included 47 subjects with an increased&nbsp;NEU, but physiological values of IG; group C was formed of 52 patients with neutrophilia combined with elevated IG.&nbsp;The median neutrophil count and IG of group C were 16.56x10<sup>9</sup>/L [interquartile range (IQR): 11.01-21.87] and 6.2%&nbsp;(IQR: 4.2-9.9), respectively. At multivariate analysis, IG emerged as the best predictor of 24-month mortality (hazard&nbsp;ratio, 2.62; P=0.006). Kaplan-Meier analysis showed a significant worsening in the survival of patients with presence&nbsp;of IG during hospitalization (87.2%, 71.2% and 41.9% for A, B and C group, respectively). Elevated NEU and IG&nbsp;predict future adverse events in cardiopulmonary patients and might be included in a risk prediction algorithm.</p>
Biochimica Clinica ; 40(3) 225-228
Contributi scientifici - Scientific Papers